No. I'll re-word it for you since it's a point of contention.
@Mason14 If you have time can you take a look at the clinical trials and share your thoughts positive or negative on the science like you have done with other companies. Thank you.
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-64
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $101.4M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 30.0¢ | 29.0¢ | $40.16K | 137.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 66491 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 33118 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |